Search
for
Sort by
Research 181–210 of 1000+
- The Roles of the Lrig1- and Lgr6-Positive Stem Cells in the Skin and the Functions of the Molecular Markers That Define Them
- Cutaneous toxicities of cancer therapy
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Prophylaxis and Management of Skin Toxicities
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Signal integrator function of CXXC5 in Cancer
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- 12. Cancer
- Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- 15809 Spironolactone use does not increase the risk of estrogen-dependent cancer recurrence: A retrospective analysis
- Successful Treatment of Nipple Adenoma Using Mohs Micrographic Surgery to Preserve the Nipple–Areolar Complex
- Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
- Chaperones as thermodynamic sensors
- What was your diagnosis?
- Targeting receptor–regulator interactions
- A new way to restore tumour suppressor function
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Ginseng phytochemicals as therapeutics in oncology: Recent perspectives
- High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole
- Self-Assessment
- Repurposing of Various Current Medicines as Radioprotective Agents
- 308 Epidermal keratinocytes regulate bacterial immune responses and host defense through EGFR
- Actinic keratosis: a clinical and epidemiological revision